Drug Repurposing for Inclusion of COVID-19-Related Indication: Field Study of the European Medicines Agency’s Response to the Pandemic
As one of the biggest challenges for healthcare in the 21st century, COVID-19 placed a sustained and intense demand on the European Medicines Agency’s resources and required constant adaptation and mobilization of different regulatory processes. In this situation, drug repurposing appeared as a prom...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI AG
2025-12-01
|
| Col·lecció: | Pharmacy |
| Matèries: | |
| Accés en línia: | https://www.mdpi.com/2226-4787/13/6/179 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|